Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
29 March 2019 | Story Lacea Loader

No deregistration of students at the University of the Free State (UFS) will be effected until after the Financial Appeals Committee has concluded its process on 5 April 2019.

During a meeting between the university management and the Institutional Student Representative Council (ISRC) today, the following agreement was reached:

  1. The date for the submission of appeals has been extended to Tuesday 2 April 2019 at 12:00. No further extension will be given. The application form for the Financial Appeals Committee has previously been sent to the ufs4life email addresses of all provisionally registered students.
  2. Students who have appealed their National Student Financial Aid Scheme (NSFAS) outcomes will not be deregistered while awaiting the result of the outcome of their appeal.
  3. Verified final-year students who are provisionally registered will not be deregistered. This will be subject to verification by the Financial Appeals Committee. These students must also submit an appeal.
  4. All other categories of students must submit their appeals to the Financial Appeals Committee.

NB: The documentation mentioned above must be submitted to the Student Finance Office as indicated on the financial appeals form sent to students via their ufs4life email address.

The UFS has taken a pro-poor approach to assist students who are academically deserving. With this approach, the university’s fee structure is much less than that of many public institutions of higher learning in the country. Senior students are also supported through a provisional registration process that grants them the opportunity to pay a reduced amount in order to register, enabling them to fully participate in all activities while extension is provided to secure the necessary funding for their studies.

The university has made a number of concessions to ensure that students are not financially excluded during the 2019 academic year. Many of these concessions were raised by the ISRC on behalf of students and was agreed upon by the university management.  

These concessions include:

  1. Students who have confirmed NSFAS funding for 2019 with historic debt, are to secure registration. This has taken place before the announcement on 24 March 2019 by the Minister of Higher Education and Training, Naledi Pandor, that the historic debt of NSFAS students will be settled by the department.

     

  2. Students in the missing middle who received a gap grant in 2018, have been assisted to pay a lesser amount to register fully for 2019.

     

  3. Students with historic debt who are not receiving the gap grant have also been assisted to register for 2019. Acceptable payment plans for these students have been agreed upon with the university’s Student Finance Office.

     

  4. First-time entering students were assisted with a reduced first payment to enable them to register for 2019.

     

  5. Final-year students with historic debt of less than R20 000 who could not have been assisted in any of the above concessions explained above were allowed to register.

     

  6. Students who are provisionally registered and who could not find the necessary financial means, had the opportunity to submit appeals to the Financial Appeals Committee by 29 March 2019 to secure their registration. This committee comprises representatives of the university management, as well as members of the ISRC. This committee is scheduled to meet on 5 April 2019.

The above is evidence of the multi-layered efforts by the university to support academic deserving students as far as it is practically possible in order to avoid financial exclusion. Additionally, the university’s Student Finance Office has since the beginning of the academic year communicated extensively on the process with students who are at risk of being deregistered.  

Historically, less than 0,5% of registered students at the UFS are not able to find the necessary means to secure their registration.

To support students in their academic efforts, all matters pertaining to registration should be concluded by the end of the first term. A cut-off date is set by which all registration processes – including concessions – are to be concluded. This date – 31 March 2019 – has already been set in 2018, which is the result of consultation with all relevant stakeholders, including the IRSC.

This cut-off date has now been extended to Tuesday 2 April 2019 at 12:00.

Released by:

Lacea Loader (Director: Communication and Marketing)
Telephone: +27 51 401 2584 | +27 83 645 2454
Email: news@ufs.ac.za | loaderl@ufs.ac.za
Fax: +27 51 444 6393



News Archive

Science is diversifying the uses of traditional medicines
2017-07-17

Description: Dr Motlalepula Matsabisa  Tags: traditional medicines, Indigenous Knowledge Systems, Dr Motlalepula Matsabisa, Malaria, priority disease  

Dr Motlalepula Matsabisa.
Photo: Anja Aucamp

According to the World Health Organisation, a large majority of the African population are making use of traditional medicines for health, socio-cultural, and economic purposes. In Africa, up to 80% of the population uses traditional medicines for primary healthcare.

The Indigenous Knowledge Systems (IKS) was identified as a lead programme under the directorship of Dr Motlalepula Matsabisa. Research undertaken by the IKS Lead Programme focuses on some key priority diseases of the country and region – including malaria, HIV, cancer, and diabetes.
 
Not just a plant or tree

Malaria is a priority disease and is prevalent in rural and poor areas, resulting in many traditional health practitioners claiming to treat and cure the disease. There may well be substance to these claims, since as much as 30% of the most effective current prescription medicines are derived from plants.  For instance, chloroquine, artemisinin for malaria, Metformin for diabetes, Vincristine and Vinblastine for cancer, are plant-derived drugs.  

Dr Matsabisa’s current research is investigating a South African medicinal plant that has been shown to have in vitro antiplasmodial activity, with subsequent isolation and characterisation of novel non-symmetrical sesquiterpene lactone compounds offering antimalarial activity. These novel compounds are now patented in South Africa and worldwide. This research is part of the UFS and South Africa’s strive to contribute to the regional and continental malaria problem. The UFS are thus far the only university that has been granted a permit by the Medicines Control Council to undertake research on cannabis and its potential health benefits.

“All of these projects are aimed
at adding value through the scientific
research of medicinal plants, which
can be used for treating illnesses,
diseases, and ailments.”

Recognition well deservedThrough Dr Matsabisa’s research input and contributions to the development of the pharmacology of traditional medicines, he recently became the first recipient of the International Prof Tuhinadrin Sen Award from the International Society of Ethnopharmacology (ISE) and the Society of Ethnopharmacology in India. ISE recognises outstanding contributions by researchers, scientists, and technologists in the area of medicinal plant research and ethnopharmacology internationally.

More recently, Dr Matsabisa undertook research projects funded by the National Research Foundation, as well as the Department of Science and Technology, on cancer, gangrene, and diabetes. He is also involved in a community project to develop indigenous teas with the community. He says, “All of these projects are aimed at adding value through the scientific research of medicinal plants, which can be used for treating illnesses, diseases, and ailments”.

Dr Matsabisa has worked with many local and international scientists on a number of research endeavours. He is grateful to his colleagues from the Department of Pharmacology in the Faculty of Health Sciences, who are dedicated to science research and the research of traditional medicines. The IKS unit also received immense support from the Directorate of Research Development.

 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept